Dr. Barouch is Associate Professor of Medicine in the Division of Cardiology, Department of Medicine, and a member of the Advanced Heart Failure and Cardiac Transplantation group at Johns Hopkins Hospital. Dr. Barouch received her undergraduate degree from Harvard University in 1992 and her medical degree from Johns Hopkins in 1996. She continued at Johns Hopkins for residency training in Internal Medicine, completed in 1999, and fellowship in Cardiovascular Disease and Advanced Heart Failure/Transplant, completed in 2003. She has expertise in the outpatient management of advanced heart failure and many types of cardiomyopathies. Dr. Barouch also has a longstanding interest in women’s cardiovascular health – particularly in how some cardiac conditions affect women differently or present with distinctive symptoms. She is the Medical Director of the Columbia Heart Failure Clinic, in partnership with Johns Hopkins Howard County Medical Center, and the Howard County Director of the Women’s Cardiovascular Health Center. She is also the Director of the Sports Cardiology Program, which offers expert cardiac care specifically geared towards athletes of all abilities. Dr. Barouch believes that educating people about heart disease, medications and lifestyle changes, including healthy eating habits and regular exercise, is critically important in helping her patients understand how to achieve and maintain wellness and feel in control of their cardiovascular health. She is an avid runner and triathlete herself, competing in several triathlons and other races per year, as well as the occasional marathon. Dr. Barouch is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Cardiomyopathy, Cardiac Amyloidosis, Arrhythmogenic Right Ventricular Cardiomyopathy, and Primary Localized Cutaneous Amyloidosis.

Merrill Ansher is a Neurologist in Columbia, Maryland. Dr. Ansher is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Seizures, Familial Neurocardiogenic Syncope, Delirium, and Generalized Tonic-Clonic Seizure.

Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Primary Localized Cutaneous Amyloidosis, Cardiac Amyloidosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, and Cardiac Ablation.

Gary Milles is a primary care provider, practicing in Internal Medicine in Elkridge, Maryland. Dr. Milles is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Sitosterolemia, High Cholesterol, Primary Localized Cutaneous Amyloidosis, and Cerebral Amyloid Angiopathy.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Ritu Vyas is a Nephrologist and a Public Health and Preventive Medicine provider in Catonsville, Maryland. Dr. Vyas has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Kidney Transplant. Dr. Vyas is currently accepting new patients.

Dr. Victor Urrutia serves as the medical director of the stroke service at The Johns Hopkins Hospital and director of the Sheikh Khalifa Stroke Institute. He focuses on the clinical aspects of cerebrovascular disease (stroke), specifically acute stroke therapy and prevention. Dr. Urrutia currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesdays, and cares for patients in The Johns Hopkins Hospital's Brain Rescue Unit. Dr. Victor Urrutia received his medical degree from the University of Panama School of Medicine. He completed his neurology training at MCP Hahnemann University in Philadelphia, now Drexel University College of Medicine. After his residency training, he completed fellowship training in neurocritical care and acute stroke at Drexel University College of Medicine and became a faculty member in the neurocritical care and acute stroke division. He then returned to Panama for two years where he was the first to treat patients with IV thrombolytic therapy for acute stroke. Dr. Urrutia is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Vertigo, Thrombectomy, and Gastrostomy.

Dr. Emmanouil Tampakakis is an Assistant Professor of Medicine at Johns Hopkins University School of Medicine as well as an attending physician at Johns Hopkins Hospital. His research focuses on Stem Cell Biology and Heart Development and Regeneration. Specifically, Dr. Tampakakis lab aims to understanding the biology and regenerative potential of stem cell-derived cardiomyocytes and uses human induced pluripotent stem cells and animal models to model human cardiac disease and deciphering the mechanisms of cardiac maturation. Dr. Tampakakis also holds a cardiology fellowship at Johns Hopkins Hospital. Dr. Tampakakis received his undergraduate degree and M.D. from the University of Crete. He completed an internal medicine residency at Boston University Medical Center. Prior to joining Johns Hopkins in 2012, Dr. Tampakakis was a research fellow in Dr. J. Vita’s laboratory of Vascular Biology at Boston University School of Medicine. At Johns Hopkins, he was a post-doc in the labs of Drs Chulan Kwon and David Kass. Dr. Tampakakis is the recipient of several awards including the AHA outstanding early career investigator award and the ACC Presidential Career Development Award and has received funding from the AHA and the NIH. Videos Meet Our Expert - Emmanouil Tampakakis Recent News Articles and Media Coverage Hopkins researchers discover newborn rats hold secret to manufacturing human heart cells., The Baltimore Sun, (February 11, 2017). Dr. Tampakakis is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, and Heart Failure.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Neurologist Michelle C. Johansen specializes in prevention and treatment of stroke. She is the inaugural Guy McKhann Associate Professor of Neurology — the title was established in honor of the founder of the Johns Hopkins Department of Neurology. Dr. Johansen’s research and clinical interests focus on stroke etiology and vascular contributions to cognitive decline. She studies the intersection between the brain and the heart, specifically how changes in the heart’s structure and function point toward the cause of stroke and impact brain health, including cognition. She received the American Stroke Association’s Vascular Cognitive Impairment Award for her work showing that myocardial infarction is associated with acute and progressive decline in cognition, the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Johns Hopkins Department of Neurology’s Clinical Faculty Brain Award for excellence in teaching. She has received multiple grants to fund her research from the National Institute of Neurological Disorders and Stroke, the National Institute on Aging and the American Heart Association. Dr. Johansen’s work has been published in many high-ranking medical journals such as The Journal of the American Medical Association, and she has been interviewed as an expert for news outlets such as CNN and Medical News Today, as well as for webinars and podcasts. She is a member of the American Neurological Association and chair of its Education Innovation Committee, and she is a fellow of the American Heart Association. She received her medical degree from the Medical College of Virginia, where she was inducted into the Alpha Omega Alpha Honor Society, and she earned a postdoctoral degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Johansen completed a medicine internship and neurology residency at the University of Virginia, followed by a clinical fellowship in cerebrovascular neurology at Johns Hopkins. She joined the Johns Hopkins Department of Neurology faculty in 2017. The Johansen Lab: johansenlab.org Videos Johns Hopkins Medicine A Woman's Journey Executive Women's Briefing 2021 Neurology: Junior Faculty Spotlight. Dr. Johansen is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Stroke, Dementia, Apoplexy, Cerebral Amyloid Angiopathy, and Thrombectomy.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. Barney J. Stern is a neurologist specializing in vascular neurology and neurological complications of sarcoidosis. His work in vascular neurology has covered all aspects of stroke management, including prevention and acute, subacute and chronic care. Dr. Stern also provides complex care management for patients suffering from neurosarcoidosis. His research focuses on understanding the biology and clinical outcomes of neurovascular disease and neurological complications associated with sarcoidosis. Dr. Stern has served as the medical safety monitor on a number of National Institutes of Health (NIH) stroke studies. In his new role at Johns Hopkins, Dr. Stern will be seeing outpatients as a member of the Advanced Clinical Neurology division with Dr. John Probasco. Dr. Stern is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Neurosarcoidosis, Stroke, Herpes Zoster Oticus, Arachnoiditis, and Thrombectomy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.